Viewing Study NCT04689035


Ignite Creation Date: 2025-12-24 @ 10:39 PM
Ignite Modification Date: 2025-12-25 @ 8:10 PM
Study NCT ID: NCT04689035
Status: COMPLETED
Last Update Posted: 2023-07-20
First Post: 2020-12-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability and Pharmacokinetics of AVLX-144
Sponsor: Avilex Pharma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module